Regenerative medicine company Orthocell (ASX:OCC) has announced the successful completion of its Remplir 510(k) nerve repair study. …
Orthocell says it has achieved all endpoints in pivotal of nerve repair product
December 2, 2024 Australian Biotech
Latest Video
New Stories
-
Brisbane health-tech unveils advanced manufacturing facility
December 2, 2024 - - Latest News -
Pharmac minister celebrates increase in access to medicines following budget boost
December 2, 2024 - - Latest News -
Orthocell says it has achieved all endpoints in pivotal of nerve repair product
December 2, 2024 - - Australian Biotech -
AusBiotech welcomes experienced industry executive to its board
December 2, 2024 - - Latest News -
4DMedical signs contract to expand in Western Australia
December 2, 2024 - - Australian Biotech -
NSW government backs down on health tax in new agreement with health funds
December 2, 2024 - - Other Health -
PBS listing for Australian adults living with adults with Von Hippel-Lindau disease
December 2, 2024 - - Latest News